
Pro-marijuana groups claim reclassification would be good for businesses
The Trump administration is looking to reclassify marijuana as a less dangerous drug, which could lessen criminal penalties and expand banking opportunities for companies in the business.
President Donald Trump said he could make a decision on the reclassification in the next few weeks.
Marijuana is currently considered a schedule I drug alongside heroin and crack cocaine. Schedule I means it has a high potential for abuse or misuse.
Paula Savchenko, founder of the cannabis licensing consultant cannacore group, said this classification limits operations for businesses that try to sell marijuana.
“If we have marijuana reclassification, that would be transformative for the industry because it would help with a lot of the issues that we have in operating in the industry,” Savchenko said.
In 1982, Congress passed section 280E of the tax revenue code. The section contains a provision limiting businesses involved in selling Schedule I and Schedule II substances from deducting business expenses like rent, utilities or employee wages.
Savchenko said this restriction makes it so businesses are essentially paying 50% in taxes. She said it is “almost impossible” for the businesses that sell marijuana to be profitable.
“These companies are doing their best to operate lean and be profitable and make money but it’s really, really difficult to do that,” Savchenko said.
Apart from business considerations, Savchenko said rescheduling marijuana would create more opportunities for research and create greater economic opportunities.
Even with declassification, Savchenko said the decision would still be up to state governments on how they wish to proceed with regulation marijuana. Still, she said Trump’s consideration is an exciting move for the industry.
“I think it will just lift this huge cloud that’s been over the industry for a long time now,” Savchenko said.
Marijuana and marijuana products are illegal under federal law. However, recreational use of marijuana has been approved in 24 states, including California, Missouri and Maine.
Latest News Stories

Pew: U.S. immigrant population declines for first time in nearly 60 years

WATCH: Illinois’ FY23 financial audit released amid criticism of tardy reports

European Union says U.S. consumers will end up paying tariffs

Illinois quick hits: Anti-SLAPP bill signed; Chicago schools settles meditation case

U.S.-EU trade deal includes ceiling for European pharmaceutical imports

Supreme Court allows Trump to block DEI funding

Trump to probe Smithsonian museums for ‘woke’ ideology

Director: Nation’s largest outdoor ag show brings economic impact to central IL

Personnel cuts to national intelligence office will save taxpayers $700 million

Redistricting would split cities, counties throughout CA

Pritzker: Fair maps in Illinois would be ‘disarming’ to Democrats

NY appeals court overturns Trump’s civil fraud penalty
